Olivier Govaere
0000-0002-4426-6930
Publication & Citation Trends
Publications
160 total
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis.
Cited by 3
Semantic Scholar
Insulin-like Growth Factor-1 reflects liver disease stage and improves prediction of liver-related mortality. OA
Cited by 3
Semantic Scholar
FRI-366 Integrated analysis of the liver tissue proteome and transcriptome in metabolic dysfunction-associated steatotic liver disease (MASLD) reveals an evolving pathophysiological milieu that may support identification of novel therapeutic targets
Cited by 0
Semantic Scholar
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation.
Cited by 3
Semantic Scholar
OS-056 Integrative spatial proteomics and transcriptomics of patient liver tissues unravel Claudin-1 as a mediator and therapeutic target for primary sclerosing cholangitis
Cited by 0
Semantic Scholar
Reply to Diabetes-Driven Remodeling of Mesenteric Adipose Tissue: Insights into Macrophage Infiltration and Adipokine Dyshomeostasis.
Cited by 0
Semantic Scholar
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment. OA
Cited by 5
Semantic Scholar
Scientific Business Abstracts.
Cited by 0
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(72)
Liver physiology and pathology
(25)
Diet, Metabolism, and Disease
(19)
Liver Diseases and Immunity
(16)
Cancer Cells and Metastasis
(14)
Affiliations
Ulsan College
Université Libre de Bruxelles
University of Bonn
Morpho (United States)
Universitair Ziekenhuis Leuven